High Free Cash Flow Stocks
NVST is currently part of our High Free Cash Flow Stocks screen, indicating it generates strong cash flows relative to its price.
NYSE:NVST • US29415F1049
The current stock price of NVST is 26.33 USD. Today NVST is up by 1.5%. In the past month the price increased by 2.01%. In the past year, price increased by 54.97%.
NVST currently appears in the following ChartMill screener lists.
NVST is currently part of our High Free Cash Flow Stocks screen, indicating it generates strong cash flows relative to its price.
NVST appears in our Breakout Setups screen. This means the stock shows strong technical strength, a constructive consolidation pattern, and enough volatility to support a potential breakout if price moves above resistance.
ChartMill assigns a technical rating of 7 / 10 to NVST. When comparing the yearly performance of all stocks, NVST is one of the better performing stocks in the market, outperforming 85.03% of all stocks.
ChartMill assigns a fundamental rating of 5 / 10 to NVST. Both the profitability and the financial health of NVST get a neutral evaluation. Nothing too spectacular is happening here.
On February 5, 2026 NVST reported an EPS of 0.38 and a revenue of 750.60M. The company beat EPS expectations (15.44% surprise) and beat revenue expectations (8.23% surprise).
20 analysts have analysed NVST and the average price target is 29.49 USD. This implies a price increase of 11.99% is expected in the next year compared to the current price of 26.33.
For the next year, analysts expect an EPS growth of 19.87% and a revenue growth 7.6% for NVST
NVST is currently included in the following stock indexes tracked on ChartMill.
Over the last trailing twelve months NVST reported a non-GAAP Earnings per Share(EPS) of 1.2. The EPS increased by 64.38% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 1.73% | ||
| ROA | 0.83% | ||
| ROE | 1.51% | ||
| Debt/Equity | 0.47 |
NVST operates in the Health Care Equipment sub-industry within the Health Care sector. This group contains 127 stocks and is scored by ChartMill on both price strength and growth momentum.
Each rank shows how many other sub-industries were outperformed over that timeframe.
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ISRG | INTUITIVE SURGICAL INC | 39.25 | 162.529B | ||
| ABT | ABBOTT LABORATORIES | 14.24 | 157.763B | ||
| SYK | STRYKER CORP | 17.41 | 120.688B | ||
| BSX | BOSTON SCIENTIFIC CORP | 14.31 | 85.619B | ||
| EW | EDWARDS LIFESCIENCES CORP | 24.9 | 48.141B | ||
| IDXX | IDEXX LABORATORIES INC | 38.32 | 44.539B | ||
| BDX | BECTON DICKINSON AND CO | 10.94 | 42.438B | ||
| RMD | RESMED INC | 16.7 | 31.148B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 10.74 | 27.761B | ||
| DXCM | DEXCOM INC | 20.18 | 22.918B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 9.11 | 15.956B | ||
| PEN | PENUMBRA INC | 63.83 | 12.837B | ||
| GMED | GLOBUS MEDICAL INC - A | 20.03 | 12.197B |
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the New York Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
Envista Holdings Corp. engages in the manufacturing and marketing of dental products, diagnostics, treatment, and trading. The company is headquartered in Brea, California and currently employs 12,000 full-time employees. The company went IPO on 2019-09-18. The firm's diversified portfolio of solutions covers a range of dentists' clinical needs for preventing, diagnosing, and treating dental conditions as well as improving the aesthetics of the human smile. The company has more than 30 dental brands, including Nobel Biocare, Ormco, DEXIS and Kerr. Its segments include Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment primarily develops, manufactures and markets dental implant systems, including regenerative solutions, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners and lab products. The Equipment & Consumables segment primarily develops, manufactures, and markets dental equipment and supplies used in dental offices, including digital imaging systems, software, and other visualization/magnification systems; and endodontic systems and related products.
IPO: 2019-09-18
ENVISTA HOLDINGS CORP
200 S. Kraemer Blvd., Bldg. E
Brea CALIFORNIA 92821 US
CEO: Amir Aghdaei
Employees: 12000
Phone: 17148175418
Envista Holdings Corp. engages in the manufacturing and marketing of dental products, diagnostics, treatment, and trading. The company is headquartered in Brea, California and currently employs 12,000 full-time employees. The company went IPO on 2019-09-18. The firm's diversified portfolio of solutions covers a range of dentists' clinical needs for preventing, diagnosing, and treating dental conditions as well as improving the aesthetics of the human smile. The company has more than 30 dental brands, including Nobel Biocare, Ormco, DEXIS and Kerr. Its segments include Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment primarily develops, manufactures and markets dental implant systems, including regenerative solutions, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners and lab products. The Equipment & Consumables segment primarily develops, manufactures, and markets dental equipment and supplies used in dental offices, including digital imaging systems, software, and other visualization/magnification systems; and endodontic systems and related products.
The current stock price of NVST is 26.33 USD. The price increased by 1.5% in the last trading session.
NVST does not pay a dividend.
NVST has a ChartMill Technical rating of 7 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
The Revenue of ENVISTA HOLDINGS CORP (NVST) is expected to grow by 7.6% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
ENVISTA HOLDINGS CORP (NVST) will report earnings on 2026-05-06, after the market close.
The outstanding short interest for ENVISTA HOLDINGS CORP (NVST) is 6.83% of its float.